Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: The chemical structure of (a) kanamycin 2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl) tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-tetrahydropyran-3,4,5-triol and (b) ciprofloxacin 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: XRD pattern of Fe3O4@KNM NPs

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: XRD pattern of Fe3O4@CFX NPs

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: FTIR spectra (a) pristine kanamycin, (b) Fe3O4@KNM, and (c) pristine Fe3O4

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: FTIR spectra (a) pristine ciprofloxacin, (b) Fe3O4@CFX, and (c) pristine Fe3O4

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: UV spectra of pure ciprofloxacin (1) 4.5 μg ml−1; (2) 5 μg ml−1; (3) 6 μg ml−1; (4) 8 μg ml−1 (5) 8.5 μg ml−1; (6) 10 μg ml−1; and (7) Fe3O4@CFX found 9 μg ml−1

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: (a) SEM image of Fe3O4@KNM NPs and (b) ED pattern of Fe3O4@KNM NPs

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: (a) SEM image of Fe3O4@CFX NPs and (b) ED pattern of Fe3O4@CFX NPs

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: MIC of kanamycin and Fe3O4@KNM NPs against S. aureus are, respectively, 5 μg ml−1 and 1 μg ml−1

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: The graphic representation of inhibition of P. aeruginosa biofilm development in the presence of kanamycin and Fe3O4@KNM NPs

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: The graphic representation of inhibition of S. aureus biofilm development in the presence of kanamycin and Fe3O4@KNM NPs

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: MIC of ciprofloxacin and Fe3O4@CFX NPs against S. aureus and P. aeruginosa equal to 0,1 μg ml−1

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: The graphic representation of inhibition of P. aeruginosa biofilm development in the presence of ciprofloxacin and Fe3O4@CFX NPs

Date of download: 11/12/2017 Copyright © ASME. All rights reserved. From: The Improvement of Antimicrobial Activity of Kanamycin and Ciprofloxacin Antibiotics Coupled With Biocompatible Magnetite Nanoparticles and Characterization of Their Structure J. Nanotechnol. Eng. Med. 2016;6(4):041006-041006-7. doi:10.1115/1.4033126 Figure Legend: The graphic representation of inhibition of S. aureus biofilm development in the presence of ciprofloxacin and Fe3O4@CFX NPs